Companies: 10,795·Total market cap: $144.5T
Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.

ACHVNASDAQHealthcare● Active
$5.48
+$0.35(+6.82%)
Market Cap$562571320
P/E Ratio
52W High$6.15
52W Low$2
Overview

Achieve Life Sciences, Inc. (ACHV) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ACHV · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.12achv eps ttm · achv earnings per shareEarnings history
PE Ratio (TTM)achv pe ratio ttm · achv price to earningsPE Ratio deep dive
Revenue (TTM)0.00achv revenue ttm · achv annual revenueFull revenue history
Dividend YieldNo Dividenddoes achv pay dividends · achv dividend yieldDividend history
Shares Outstanding43.6Machv shares outstanding · achv floatShares outstanding history
Next EarningsAug 6, 2026Est.achv earnings date · achv next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
achieve life sciences, inc. revenue · achv revenue 2025
FY 2025Net Income-$54.6M▼ 37.21% YoY
202320242025
achieve life sciences, inc. net income · achv profit 2025
FY 2025EPS$-1.25▼ 0.81% YoY
202320242025
achv eps · achieve life sciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$52.0MEPS: $-1.12View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis achv a buy · achv analyst rating
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$13.00Low
$5.48Current
$13.00Avg Target137.23% upside
$13.00High
achv price target · achv 12 month forecast

Total: 6 · Buy rate: 100.0%

The ACHV analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +137.23% upside from the current price of $5.48.

Stock Performance

Full History
1D+3.97%
1W+6.67%
1M+2.37%
3M+24.91%
YTD+7.32%
1Y+41.85%
5Y-39.18%

About Achieve Life Sciences, Inc.

CEORichard A. Stewart
IPO DateOct 12, 1995
Employees25
CountryCA

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smokin…

what is achieve life sciences, inc. · achv stock overview · achieve life sciences, inc. company profile · who is achieve life sciences, inc. ceo · achv NASDAQ · achieve life sciences, inc. headquarters · achieve life sciences, inc. business segments

About Stock Overview & Key Data

Achieve Life Sciences, Inc. (ACHV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 12, 1995. As of the latest trading session, ACHV stock price is $5.48, with a market capitalization of $562.6M. The stock has returned +41.85% over the past 12 months and +7.32% year-to-date.

According to 6 Wall Street analysts, the consensus rating for Achieve Life Sciences, Inc. stock is Buy, with an average 12-month price target of $13.00. In fiscal year 2025, Achieve Life Sciences, Inc. reported revenue of — and net income of -$54.6M. For detailed data — including Achieve Life Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Achieve Life Sciences, Inc. (ACHV) stock price is $5.48. The stock is traded on NASDAQ under the ticker symbol ACHV. The 52-week range is $2.00 – $6.15.

ACHV stock priceACHV quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice